Welcome to MorphoSys
Turning Technology into Products
MorphoSys is an independent biotechnology company that develops novel antibodies for therapeutic, diagnostic and research applications.
The Company’s HuCAL antibody library is one of the most powerful methods available for generating fully human antibodies. By successfully applying this and other proprietary technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human health-care. Via its business unit AbD Serotec, MorphoSys is expanding the reach of its technologies in the diagnostics and research markets.
Through its alliances with some of the world’s leading pharmaceutical companies, MorphoSys has created a pipeline of more than 60 drug candidates. The Company is expanding its drug pipeline by adding new partnered programs, and by building a portfolio of fully-owned therapeutic antibodies. For its proprietary portfolio, the Company is focused on the areas of oncology and inflammation. Its most advanced program is MOR103, a first-in-class, fully human antibody against GM-CSF.